397030 — AprilBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩1tn
- KR₩2bn
Annual cashflow statement for AprilBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -52,713 | -8,959 | -14,130 | 20,005 | -9,728 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 57,511 | -1,873 | 1,690 | -812 | 2,385 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,033 | 3,535 | 1,707 | 2,060 | 3,311 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,252 | -6,704 | -10,059 | 21,960 | -3,342 |
| Capital Expenditures | -706 | -89.6 | -512 | -445 | -288 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -23,094 | -31,552 | -6,542 | -22,352 | 5,893 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -23,800 | -31,642 | -7,054 | -22,797 | 5,605 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 34,793 | 20,328 | 16,312 | -2,513 | 1,475 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14,245 | -17,093 | -697 | -3,240 | 3,726 |